ADP-ribosylation factor like GTPase 6 interacting protein 5
RGD ID:
708572
Description:
Enables transmembrane transporter binding activity. Involved in negative regulation of transport and regulation of neurotransmitter uptake. Located in cytoplasm and membrane. Orthologous to human ARL6IP5 (ADP ribosylation factor like GTPase 6 interacting protein 5); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil; ammonium chloride.
ADP-ribosylation factor-like 6 interacting protein 5; ADP-ribosylation factor-like protein 6-interacting protein 5; ADP-ribosylation-like factor 6 interacting protein 5; aip-5; ARL-6-interacting protein 5; glutamate transporter EAAC1 interacting protein; glutamate transporter EAAC1-interacting protein; Gtrap3-18; PRA1 family protein 3; prenylated Rab acceptor protein 2; protein JWa
ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin], ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin]
ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin], ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin]
[arsenite co-treated with Benzo(a)pyrene] results in increased expression of ARL6IP5 mRNA, [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA
[arsenic trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein, CAT protein inhibits the reaction [[arsenic trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein]
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [ARL6IP5 mutant form inhibits the reaction [Morphine results in increased expression of OPRD1 protein]]
